These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34480482)

  • 1. The global incidence of bullous pemphigoid: a systematic review and meta-analysis.
    Persson MSM; Begum N; Grainge MJ; Harman KE; Grindlay D; Gran S
    Br J Dermatol; 2022 Mar; 186(3):414-425. PubMed ID: 34480482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global incidence and prevalence of bullous pemphigoid: A systematic review and meta-analysis.
    Lu L; Chen L; Xu Y; Liu A
    J Cosmet Dermatol; 2022 Oct; 21(10):4818-4835. PubMed ID: 35080093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.
    Brick KE; Weaver CH; Lohse CM; Pittelkow MR; Lehman JS; Camilleri MJ; Al-Hashimi M; Wieland CN
    J Am Acad Dermatol; 2014 Jul; 71(1):92-9. PubMed ID: 24704091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid: A Meta-analysis.
    Tedbirt B; Gillibert A; Andrieu E; Hébert V; Bastos S; Korman NJ; Tang MBY; Li J; Borradori L; Cortés B; Kim SC; Gual A; Xiao T; Wieland CN; Fairley JA; Ezzedine K; Joly P
    JAMA Dermatol; 2021 Apr; 157(4):421-430. PubMed ID: 33729430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of exposure to long working hours on stroke: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Descatha A; Sembajwe G; Pega F; Ujita Y; Baer M; Boccuni F; Di Tecco C; Duret C; Evanoff BA; Gagliardi D; Godderis L; Kang SK; Kim BJ; Li J; Magnusson Hanson LL; Marinaccio A; Ozguler A; Pachito D; Pell J; Pico F; Ronchetti M; Roquelaure Y; Rugulies R; Schouteden M; Siegrist J; Tsutsumi A; Iavicoli S
    Environ Int; 2020 Sep; 142():105746. PubMed ID: 32505015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    Zhou Q; Xiong Z; Yang D; Xiong C; Li X
    PLoS One; 2023; 18(11):e0295135. PubMed ID: 38033098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
    Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
    Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
    Ungprasert P; Wijarnpreecha K; Thongprayoon C
    Indian J Dermatol Venereol Leprol; 2018; 84(1):22-26. PubMed ID: 29185440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis.
    Jiirasutat N; Pongchareon P; Weschawalit S
    Int J Dermatol; 2024 May; 63(5):572-579. PubMed ID: 38217028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital.
    Försti AK; Jokelainen J; Timonen M; Tasanen K
    Br J Dermatol; 2014 Nov; 171(5):1223-6. PubMed ID: 24934834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
    Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
    Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
    Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of occupational exposure to noise on ischaemic heart disease, stroke and hypertension: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-Related Burden of Disease and Injury.
    Teixeira LR; Pega F; Dzhambov AM; Bortkiewicz A; da Silva DTC; de Andrade CAF; Gadzicka E; Hadkhale K; Iavicoli S; Martínez-Silveira MS; Pawlaczyk-Łuszczyńska M; Rondinone BM; Siedlecka J; Valenti A; Gagliardi D
    Environ Int; 2021 Sep; 154():106387. PubMed ID: 33612311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of exposure to long working hours on ischaemic heart disease: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Li J; Pega F; Ujita Y; Brisson C; Clays E; Descatha A; Ferrario MM; Godderis L; Iavicoli S; Landsbergis PA; Metzendorf MI; Morgan RL; Pachito DV; Pikhart H; Richter B; Roncaioli M; Rugulies R; Schnall PL; Sembajwe G; Trudel X; Tsutsumi A; Woodruff TJ; Siegrist J
    Environ Int; 2020 Sep; 142():105739. PubMed ID: 32505014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of exposure to long working hours on depression: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Rugulies R; Sørensen K; Di Tecco C; Bonafede M; Rondinone BM; Ahn S; Ando E; Ayuso-Mateos JL; Cabello M; Descatha A; Dragano N; Durand-Moreau Q; Eguchi H; Gao J; Godderis L; Kim J; Li J; Madsen IEH; Pachito DV; Sembajwe G; Siegrist J; Tsuno K; Ujita Y; Wang J; Zadow A; Iavicoli S; Pega F
    Environ Int; 2021 Oct; 155():106629. PubMed ID: 34144478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study.
    Krishnamurthi RV; Moran AE; Forouzanfar MH; Bennett DA; Mensah GA; Lawes CM; Barker-Collo S; Connor M; Roth GA; Sacco R; Ezzati M; Naghavi M; Murray CJ; Feigin VL;
    Glob Heart; 2014 Mar; 9(1):101-6. PubMed ID: 25432119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous pemphigoid: Its incidence, mortality and clinical outcome in New Zealand.
    Chung JG; Ramji R; Coomarasamy C; Jarrett P; Rademaker M; Patel DC
    Australas J Dermatol; 2022 May; 63(2):197-203. PubMed ID: 35324003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study.
    Persson MSM; Harman KE; Vinogradova Y; Langan SM; Hippisley-Cox J; Thomas KS; Gran S
    Br J Dermatol; 2021 Jan; 184(1):68-77. PubMed ID: 32147814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea.
    Lee H; Chung HJ; Pawar A; Patorno E; Kim DH
    JAMA Dermatol; 2020 Oct; 156(10):1107-1114. PubMed ID: 32697283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies.
    Phan K; Goyal S; Murrell DF
    Australas J Dermatol; 2019 Feb; 60(1):23-28. PubMed ID: 30141189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.